Title : Inhibition of the deubiquitinase USP10 induces degradation of SYK.

Pub. Date : 2020 Apr

PMID : 32015510






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It has also been found to be over-expressed in AML patients, with activating mutations in foetal liver tyrosine kinase 3 (FLT3), particularly those with internal tandem duplications (FLT3-ITD), where it transactivates FLT3-ITD and confers resistance to treatment with FLT3 tyrosine kinase inhibitors (TKIs). Tyrosine fms related receptor tyrosine kinase 3 Homo sapiens
2 It has also been found to be over-expressed in AML patients, with activating mutations in foetal liver tyrosine kinase 3 (FLT3), particularly those with internal tandem duplications (FLT3-ITD), where it transactivates FLT3-ITD and confers resistance to treatment with FLT3 tyrosine kinase inhibitors (TKIs). Tyrosine fms related receptor tyrosine kinase 3 Homo sapiens
3 It has also been found to be over-expressed in AML patients, with activating mutations in foetal liver tyrosine kinase 3 (FLT3), particularly those with internal tandem duplications (FLT3-ITD), where it transactivates FLT3-ITD and confers resistance to treatment with FLT3 tyrosine kinase inhibitors (TKIs). Tyrosine fms related receptor tyrosine kinase 3 Homo sapiens
4 It has also been found to be over-expressed in AML patients, with activating mutations in foetal liver tyrosine kinase 3 (FLT3), particularly those with internal tandem duplications (FLT3-ITD), where it transactivates FLT3-ITD and confers resistance to treatment with FLT3 tyrosine kinase inhibitors (TKIs). Tyrosine fms related receptor tyrosine kinase 3 Homo sapiens